Academy Military Medical Science, China
16
0
0
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 16 trials
100.0%
+13.5% vs industry average
6%
1 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Pelvic Microbiomes of Benign and Malignant Ovarian Diseases
Role: collaborator
A Clinical Study Using Adipose-derived Stem Cells for Diabetic Foot
Role: collaborator
Umbilical Cord Mesenchymal Stem Cells Infusion for Diabetes Related Vascular Complications
Role: collaborator
A Clinical Study Using Autologous Bone Marrow Stem Cell for Diabetes Related Vascular Complications
Role: collaborator
A Multi-center Study for Eradication of Refractory Helicobacter Pylori
Role: collaborator
A Multi-center Study for Individual Treatment of Helicobacter Pylori Infection
Role: collaborator
Tolerability, Safety and Pharmacokinetic Study Of Methosulide in Healthy Adult Subjects
Role: collaborator
Therapy of Preconditioned Autologous BMMSCs for Patients With Ischemic Heart Disease
Role: lead
MSC for Treatment of CMV Infection
Role: collaborator
Treatment of Chronic Graft-Versus-Host Disease With Mesenchymal Stromal Cells
Role: collaborator
MSCs Combined With CD25 Monoclonal Antibody and Calcineurin Inhibitors for Treatment of Steroid-resistant aGVHD
Role: collaborator
MSCs With or Without Peripheral Blood Stem Cell for Treatment of Poor Graft Function and Delayed Platelet Engraftment
Role: collaborator
Megakaryocytic Progenitor Cells for Prophylaxis and Treatment of Thrombocytopenia
Role: collaborator
Peripheral Blood Stem Cell Combined With Mesenchymal Stem Cells for Treatment of Poor Graft Function
Role: collaborator
Safety Study of Adenovirus Hepatocyte Growth Factor to Treat Ischemic Heart Disease
Role: collaborator
A Randomised,Multi-Center Study of Docetaxol Plus Capecitabine or Cisplatin in Anthracycline-Pretreated Patients With Advanced Breast Cancer
Role: lead
All 16 trials loaded